Group 1 - The core point of the article is that Baiyang Pharmaceutical announced the convening of its third board meeting via remote voting on August 14, 2025, to review various proposals, including the signing of agreements [2] - For the fiscal year 2024, Baiyang Pharmaceutical's revenue composition is as follows: sales of pharmaceuticals and medical devices account for 92.5%, brand services account for 7.18%, and other businesses account for 0.32% [2]

Core Insights - Chengdu International Railway Port Comprehensive Bonded Zone has achieved a milestone in the development of the pharmaceutical cold chain industry with Sichuan Lepu Kang Pharmaceutical Co., Ltd. obtaining a medical device business license, becoming the first bonded pharmaceutical enterprise in the zone with dual GSP certification for both drugs and medical devices [1][3] Group 1: Industry Development - The successful acquisition of GSP dual certification signifies a leap from non-existence to a fully functional pharmaceutical cold chain capability in the Chengdu International Railway Port Comprehensive Bonded Zone [1][4] - This development establishes a standardized, professional service capacity for pharmaceutical and medical device products, laying a solid foundation for creating a regionally influential pharmaceutical cold chain distribution center [1][4] Group 2: Regulatory and Operational Framework - GSP (Good Supply Practice) is a critical standard in the pharmaceutical industry that ensures the quality and safety of drugs and medical devices during circulation [3] - Lepu Kang has established a comprehensive and compliant management system across the entire supply chain, including procurement, storage, transportation, and sales, enabling the management of multiple categories and temperature zones of pharmaceutical products [3] Group 3: Future Prospects - The breakthrough in GSP dual certification not only enhances the company's qualifications but also represents an important practice in policy innovation within the bonded zone [4] - The development is expected to fill the gap in regional pharmaceutical bonded cold chain services, attracting more leading pharmaceutical companies and creating an industrial cluster effect [4] - The bonded zone plans to deepen its "bonded +" functions, expanding into pharmaceutical research and international distribution services, facilitating the transformation of Qingbaijiang from a traditional logistics hub to a high-value pharmaceutical supply chain center [4]